Founded in 2007, Biophore has established itself as a trusted partner for the development and manufacturing of niche pharmaceutical products. It has 4 USFDA and EU-approved API manufacturing facilities, one dedicated intermediate facility and a world-class R&D lab housing 400 scientists. Over the years, Biophore has emerged as one of the world’s leading API companies. It has consistently ranked among the top 10 US DMF filers in the last 5 years. It has filed more than 150 patents across the globe in the areas of processes and polymorphs. Its facilities have a track record of successful audits by the USFDA, EMEA, ANVISA, COFEPRIS & WHO GMP.